最高法院将决定联邦是否批准对Bayer提出的州癌症诉讼。 The Supreme Court will decide if federal approval of Roundup blocks state cancer lawsuits against Bayer.

美国最高法院将审理Bayer在一个有关围产期杂草杀手的重大案件中提出的上诉,质疑环境保护署在没有癌症警告的情况下批准甘草酸盐是否排除了声称产品造成癌症的州诉讼。 The U.S. Supreme Court will hear Bayer’s appeal in a major case over Roundup weedkiller, challenging whether the Environmental Protection Agency’s approval of glyphosate—without a cancer warning—preempts state lawsuits claiming the product causes cancer. 案件的中心是一个密苏里州的男子, 在长期使用Roundup后患上非霍奇金淋巴瘤后赢得了125万美元的判决. The case centers on a Missouri man who won a $1.25 million verdict after developing non-Hodgkin’s lymphoma from long-term Roundup use. 虽然美国环保局坚持按指示使用甘酸盐不会致癌,但一些研究表明存在关联,国际癌症研究机构将其归类为“可能的致癌性 ” 。 2018年获得Monsanto的Bayer认为,联邦先发制人应阻止各州的索赔要求,援引相矛盾的下级法院裁决并试图限制责任。 While the EPA maintains glyphosate is not likely carcinogenic when used as directed, some studies suggest a link, and the International Agency for Research on Cancer classifies it as “probably carcinogenic.” Bayer, which acquired Monsanto in 2018, argues federal preemption should block state claims, citing conflicting lower court rulings and seeking to limit liability. 该公司已拨出160亿美元用于理赔,停止销售基于glyphosate的集聚会供住宅使用,并推行禁止诉讼的州法律,格鲁吉亚和北达科他州也遵守这些法律。 The company has set aside $16 billion to settle claims, stopped selling glyphosate-based Roundup for residential use, and pushed for state laws banning lawsuits, with Georgia and North Dakota complying. Trump政府支持Bayer, 扭转拜登政府的立场。 The Trump administration supports Bayer, reversing the Biden administration’s position. 法院的裁决可能影响到大约181 000项索赔要求,并确定Bayer是否继续在美国农业中销售甘磷酸盐。 The Court’s decision could affect about 181,000 claims and determine whether Bayer continues selling glyphosate in U.S. agriculture. 辩论日期正在等待. The argument date is pending.